Radiomics features on MRI discriminate sellar LCH from tumor marker-negative GCTs with an AUC of 0.81.
This retrospective cohort study included 93 patients diagnosed pathologically or by therapeutic diagnosis with sellar region tumors. The primary objective was to discriminate between tumor marker-negative sellar germ cell tumors (GCTs) and Langerhans cell histiocytosis (LCH). The intervention involved extracting radiomics features from multiparametric MRI sequences, specifically T1WI and T2WI. These features were combined with clinical features and imaging semantic features using a random forest (RF) classifier.
The main result showed an area under the curve (AUC) of 0.81 for the combined model. Specific absolute numbers regarding sensitivity or specificity were not reported, nor were p-values or confidence intervals provided. Safety and tolerability data, including adverse events or discontinuations, were not reported. The study was conducted at a single institution, and follow-up duration was not reported.
Key limitations include the single-institution setting and the lack of reported statistical significance or safety profiles. As this is an observational study, causal language is inappropriate. The practice relevance is uncertain given the incomplete reporting of secondary outcomes and safety data.